In breast cancer cells, GPR176 silencing was shown to ameliorate proliferation and induce apoptosis by either inactivating PTEN/PI3K/Akt/mTOR or decreasing Bcl-2/Bax. This evidence concerns the gene BCL2 and breast carcinoma.